购物车
您的购物车当前为空
LAH-1, an oral c-Met inhibitor with membrane permeability, demonstrates an IC 50 of 49 nM and exhibits anticancer activities by inducing apoptosis, migration, and invasion [1].

LAH-1, an oral c-Met inhibitor with membrane permeability, demonstrates an IC 50 of 49 nM and exhibits anticancer activities by inducing apoptosis, migration, and invasion [1].
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 10-14周 | |
| 50 mg | 待询 | 10-14周 |
| 产品描述 | LAH-1, an oral c-Met inhibitor with membrane permeability, demonstrates an IC 50 of 49 nM and exhibits anticancer activities by inducing apoptosis, migration, and invasion [1]. |
| 分子量 | 548.5 |
| 分子式 | C27H22F2N6O5 |
| CAS No. | 3018150-68-7 |
| Smiles | O=C1N(N=C(C(NC2=CC(F)=C(OC=3C=C(NC(=O)N4CC(O)C4)N=CC3)C=C2)=O)C(C)=C1)C5=CC=C(F)C=C5 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
对于不同动物的给药剂量换算,您也可以参考 更多